A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland

M Hinkula, E Pukkala, P Kyyrönen, P Laukkanen, P Koskela, J Paavonen, M Lehtinen, A Kauppila, M Hinkula, E Pukkala, P Kyyrönen, P Laukkanen, P Koskela, J Paavonen, M Lehtinen, A Kauppila

Abstract

Previous studies suggest that high parity increases the risk of cervical cancer. We studied the risk of cervical cancer (CC) and cervical intraepithelial neoplasia (CIN3) in a Finnish cohort of grand multiparous (GM) women (at least five children) with low prevalence of sexually transmitted infections (STI). The Finnish Cancer Registry data revealed 220 CC and 178 CIN3 cases among 86 978 GM women. Standardised incidence ratios (SIR) were calculated from the numbers of observed and expected cases. Interval analyses by parity, age at first birth and average birth interval were done using multivariate Poisson regression. Seroprevalence of human papillomavirus (HPV) 16 and Chlamydia trachomatis was tested among 561 GM women and 5703 women with 2-4 pregnancies. The incidence among GM women was slightly above the national average for squamous cell carcinoma of cervix uteri (SIR 1.21, 95% CI 1.05-1.40) and CIN3 (1.37, 95% CI 1.17-1.58), but lower for adenocarcinoma (SIR 0.77, 95% CI 0.52-1.10). The seroprevalence of HPV16 and Chlamydia trachomatis among GM women was lower than in the reference population, except among those women who had their child under age 19. Age under 20 years at first birth increased the risk of CC and CIN3 especially in premenopausal GM women, while increasing parity had no effect. The small relative risks of CC and CIN3 among GM women in our study as compared to studies from other countries can be explained by the exceptionally low prevalence of STIs in Finnish GM women. The observed SIRs between 1.2 and 1.4 should be interpreted to represent increased risk attributable to grand multiparity. The increased incidence of CC and CIN3 among young GM women suggests causal association to HPV 16 and Chlamydia trachomatis infections.

Figures

Figure 1
Figure 1
Prevalence of HPV16 (•) and Chlamydia trachomatis (○) among GM women (solid line, —), and women with 2–4 pregnancies (dotted lines, - - -), in 1983–1993, by age at pregnancy.

References

    1. Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M (1999) Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer 83: 59–65
    1. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285: 47–51
    1. Autier PCM, Huet F, Grivegnee AR (1996) Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 74: 488–490
    1. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, Tadar L, Kaldo JM, Guerrero F, Aristizabal N, Santamaria M, Alonso de Ruiz P, Shah K (1992) Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52: 750–758
    1. Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K, Fraumeni Jr JF (1987a) Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 79: 23–30
    1. Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F (1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51: 301–306
    1. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE (1989) Parity as a risk factor for cervical cancer. Am J Epidemiol 130: 486–496
    1. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni Jr JF (1987b) Epidemiology of cervical cancer by cell type. Cancer Res 47: 1706–1711
    1. Cuzick J, Sasieni P, Singer A (1996) Risk factors for invasive cervix cancer in young women. Eur J Cancer 32A: 836–841
    1. Cuzick J, Singer A, De Stavola BL, Chomet J (1990) Case–control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 26: 684–690
    1. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89: 1293–1299
    1. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114–119
    1. Hakama M (1985) Effect of population screening for carcinoma of the uterine cervix in Finland. Maturitas 7: 3–10
    1. Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T (2000) Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control 11: 783–790
    1. Hinkula M, Pukkala E, Kyyrönen O, Kauppila A (2001) Grand multiparity and risk of breast cancer; population-based study in Finland. Cancer Causes Control 12: 491–500
    1. Hinkula M, Pukkala E, Kyyrönen P, Kauppila A (2002) Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer 98: 912–915
    1. Jones CJ, Brinton LA, Hamman RF, Stolley PD, Lehman HF, Levine RS, Mallin K (1990) Risk factors for in situ cervical cancer: results from a case–control study. Cancer Res 50: 3657–3662
    1. Korhonen MO (1980) Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 10: 312–317
    1. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85: 35–39
    1. Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 58: 820–824
    1. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G (1986) Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 123: 22–29
    1. La Vecchia C, Negri E, Franceschi S, Parazzini F (1993) Long-term impact of reproductive factors on cancer risk. Int J Cancer 53: 215–219
    1. Laukkanen P, Koskela P, Pukkala E, Dillner J, Läärä E, Knekt P, Lehtinen M (2003) Time trends in incidence and prevalence of human papillomavirus type 6,11 and 16 prevalence in Finland. J Gen Virol 84: 2105–2109
    1. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M (1996) Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case–control study. Br Med J 312: 537–539
    1. Mukherjee BN, Sengupta S, Chaudhuri S, Biswas LN, Maiti P (1994) A case–control study of reproductive risk factors associated with cervical cancer. Int J Cancer 59: 476–482
    1. Munoz N, Bosch FX, de Sanjose S, Shah KV (1994) The role of HPV in the etiology of cervical cancer. Mutat Res 305: 293–301
    1. Munoz N, Bosch FX, de Sanjose S, Vergara A, del Moral A, Munoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P, Navarro C, Alanso de Ruiz P, Anstizabal N, Santamaria M, Ordila J, Daniel RW, Guerrero E, Shah K (1993) Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2: 423–431
    1. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX, International Agency for Research on CancerMulticentric Cervical Cancer Study G (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 359: 1093–1101
    1. Nair BS, Pillai R (1992) Oncogenesis of squamous carcinoma of the uterine cervix. Int J Gynecol Pathol 11: 47–57
    1. Parazzini F, Chatenoud L, La Vecchia C, Negri E, Franceschi S, Bolis G (1998) Determinants of risk of invasive cervical cancer in young women. Br J Cancer 77: 838–841
    1. Parazzini F, La Vecchia C, Negri E, Cecchetti G, Fedele L (1989) Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia. Br J Cancer 59: 805–809
    1. Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors for adenocarcinoma of the cervix: a case–control study. Br J Cancer 57: 201–204
    1. Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L (1992) Risk factors for cervical intraepithelial neoplasia. Cancer 69: 2276–2282
    1. Rotkin ID (1973) A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 33: 1353–1367
    1. Schiffman M, Brinton LA, Devesa SS, Fraumeni Jr JF (1996) Cervical cancer. Cancer Epidemiology and Prevention, 2nd edn. pp 1090–1116. Oxford: Oxford University Press
    1. Schiffman MH, Brinton LA (1995) The epidemiology of cervical carcinogenesis. Cancer 76: 1888–1901
    1. Solomons B (1934) The dangerous multipara. Lancet 2: 8–11
    1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
    1. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633–1638
    1. . (2001) Statistics Finland, Helsinki

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe